Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.24.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Cash Flows From Operating Activities        
Net loss $ (4,979) $ (3,470) $ (14,541) $ (10,760)
Adjustments to reconcile net loss to net cash used in operating activities        
Stock based compensation expense     3,300 2,021
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets     260 150
Accounts payable and accrued expenses     662 (646)
Net cash used in operating activities     (10,319) (9,235)
Cash Flows From Investing Activities        
Purchase of property and equipment     (201) (144)
Net cash used in investing activities     (201) (144)
Cash Flows From Financing Activities        
Proceeds from sale of equity, net of issuance costs     76 24,764
Proceeds from exercise of stock options     29 214
Proceeds from exercise of warrants     0 16
Net cash provided by financing activities     105 24,994
Net increase (decrease) in cash and restricted cash     (10,415) 15,615
Cash, cash equivalents and restricted cash – Beginning of period     16,239 3,594
Cash, cash equivalents and restricted cash – Ending of period 5,824 19,209 5,824 19,209
Reconciliation of cash, cash equivalents and restricted cash:        
Cash and cash equivalents 5,768 19,184 5,768 19,184
Restricted cash (included in other assets) 56 25 56 25
Total cash, cash equivalents and restricted cash $ 5,824 $ 19,209 $ 5,824 $ 19,209